๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This randomized phase III trial studies combination chemotherapy with blina...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-05-19
Trial ID
NCT02003222
Treatments Being Tested
This is a Phase 3, multicenter, randomized, double-blind, placebo controlle...
Status
Terminated
Location
Research Site
Start Date
2014-07
Trial ID
NCT02137343
Treatments Being Tested
This is a phase 3, multicenter, randomized, double-blind, placebo controlle...
Status
Terminated
Location
Research Site
Start Date
2012-10
Trial ID
NCT01697072
Treatments Being Tested
This study is a global, multicenter, open-label phase 1b and randomized, do...
Status
Completed
Location
Multiple Locations
Start Date
2008-10-27
Trial ID
NCT00788957
Treatments Being Tested
The primary objectives of this study are the following: Phase 1b: To ident...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00770848
Treatments Being Tested
This is a phase I/II study of erlotinib and AMG 102 in previously treated s...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2011-08
Trial ID
NCT01233687
Treatments Being Tested
This screening and multi-sub-study randomized phase II/III trial will estab...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-07-08
Trial ID
NCT02154490
The purpose of this study is to evaluate the effectiveness and safety of AM...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00422019
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness and safety of AM...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00427440
Treatments Being Tested
This phase II trial is studying how well giving AMG 102 together with pemet...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01105390
Treatments Being Tested